LEGISLATIVE BUDGET BOARD

Austin, Texas

FISCAL NOTE, 89TH LEGISLATIVE REGULAR SESSION

March 28, 2025

TO:	Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services
FROM:	Jerry McGinty, Director, Legislative Budget Board
IN RE:	SB493 by Kolkhorst (Relating to certain protected disclosures or communications by pharmacists and pharmacies regarding prescription drug benefits.), Committee Report 1st House, Substituted

No significant fiscal implication to the State is anticipated.

It is assumed that any costs associated with the bill could be absorbed using existing resources.

Local Government Impact

No significant fiscal implication to units of local government is anticipated.

Source Agencies:

515 Board of Pharmacy

LBB Staff:

JMc, NPe, GDZ, DPE